Re: USA Africa Dialogue Series - Malaria vaccine

So too is Florida and the US South, a malaria zone where the vector carries Zika, Dengue, and possibly malaria parasites. Why is GlaxoSmith not jabbing in the US with four booster shots for infants? They have tried with 40% but 60% will still catch it with the jab is what they are saying; some comfort.

Chloroquine came from indigenous Americans, a Chinese won the Nobel for malaria research that led to a drug. Not surprising that a Columbian has something to do with this one. The solution may lie in Indigenous Knowledge Systems in healthcare. Keep researching.

Biko

On Thursday, 7 October 2021, 18:37:18 GMT-4, 'Emeagwali, Gloria (History)' via USA Africa Dialogue Series <usaafricadialogue@googlegroups.com> wrote:

Hopefully, but  RTS,S (Mosquirix) seems to have a 30 to 40 

percent efficacy and has to be used with 

conventional  medicaments. The administration of four 

doses and a booster  to  infants, and the sheer difficulty of 

keeping the necessary temperature is also a challenge.

There is a bit of hype by GlaxoSmithKline  and the WHO.

Afterall this vaccine has its beginnings in 1987 by Manuel Pattarroyo, 

a Columbian professor.

https://www.science.org/doi/abs/10.1126/science.7824925

Perhaps this present wall-to wall coverage diverts attention from the

paltry donations of covid19 vaccines.  Or perhaps not.

Whatever the case, they are selling this  one as a Christmas present

 to Africa.  South Asia, Southeast Asia, South America,

the Caribbean,  and the Pacific are malaria  regions, too,

and I expect that they will get some of the anticipated

 benefits from it, too, granted that Africa has the majority of cases.

Prof. Gloria Emeagwali

Professor Gloria Emeagwali
Prof. of History/African Studies, CCSU
africahistory.net; vimeo.com/ gloriaemeagwali
Recipient of the 2014 Distinguished Research
Excellence Award, Univ. of Texas at Austin;
2019 Distinguished Africanist Award
New York African Studies Association

---

From: usaafricadialogue@googlegroups.com <usaafricadialogue@googlegroups.com> on behalf of Elias K. Bongmba <bongmba@rice.edu>
Sent: Thursday, October 7, 2021 9:44 AM
To: usaafricadialogue@googlegroups.com <usaafricadialogue@googlegroups.com>
Subject: Re: USA Africa Dialogue Series - Malaria vaccine

 

Please be cautious: **External Email**

This is a real breakthrough and a spectacular development that could be
a game changer that will save millions of lives and strengthen the fight
against malaria.

Elias

On 10/6/2021 3:35 PM, Toyin Falola wrote:
> https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nytimes.com%2F2021%2F10%2F06%2Fhealth%2Fmalaria-vaccine-who.html%3FreferringSource%3DarticleShare&amp;data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082251399%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=%2Fk3tRyvt8ACkSYftEAjEZ7ICVmr6XyIZJ6WnLDdxrcA%3D&amp;reserved=0
>
>
> Sent from my iPhone
>
--
Elias Kifon Bongmba PhD, DTheo (Lund)
Harry and Hazel Chair in Christian Theology
Professor of Religion
Chair, Department of Religion
Executive Editor, the Journal of Religion in Africa
Rice university
PO Box 1892 Houston TX 77251-1892
https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Freli.rice.edu%2Ffaculty%2Felias-kifon-bongmba&amp;data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=nA3%2B%2Bo9p7q0hmHWcn7Yi6QsKR%2B2E23YLCPR%2FbZ1Ps74%3D&amp;reserved=0

--
Listserv moderated by Toyin Falola, University of Texas at Austin
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To subscribe to this group, send an email to USAAfricaDialogue+subscribe@googlegroups.com
Current archives at https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fgroups.google.com%2Fgroup%2FUSAAfricaDialogue&amp;data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=0M6vig0sRNmRsClmMrU6MoHB7cCkuD44zo0LhfcGVug%3D&amp;reserved=0
Early archives at https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.utexas.edu%2Fconferences%2Fafrica%2Fads%2Findex.html&amp;data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=3fnQDLspMqd0Omt1D28%2Fq4D%2FZveBoWeQP80%2FT27ssSg%3D&amp;reserved=0
---
You received this message because you are subscribed to the Google Groups "USA Africa Dialogue Series" group.
To unsubscribe from this group and stop receiving emails from it, send an email to usaafricadialogue+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgroups.google.com%2Fd%2Fmsgid%2Fusaafricadialogue%2F6fad9e72-e5f8-3d82-74de-3b8acdaae1ce%2540rice.edu&amp;data=04%7C01%7Cemeagwali%40ccsu.edu%7C1528c52dcd5445fdd79808d989995e17%7C2329c570b5804223803b427d800e81b6%7C0%7C0%7C637692114082261393%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=EmjeC4o504oz2NJSKQH7LrN4xAbSRePp5FwQhtA11MY%3D&amp;reserved=0.

--
Listserv moderated by Toyin Falola, University of Texas at Austin
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To subscribe to this group, send an email to USAAfricaDialogue+subscribe@googlegroups.com
Current archives at http://groups.google.com/group/USAAfricaDialogue
Early archives at http://www.utexas.edu/conferences/africa/ads/index.html
---
You received this message because you are subscribed to the Google Groups "USA Africa Dialogue Series" group.
To unsubscribe from this group and stop receiving emails from it, send an email to usaafricadialogue+unsubscribe@googlegroups.com.
To view this discussion on the web visit

https://groups.google.com/d/msgid/usaafricadialogue/BL0PR01MB451447739724107B7977BAEDDEB19%40BL0PR01MB4514.prod.exchangelabs.com

.